Prolytic

Prolytic is a German contract research organization (CRO) specializing in bioanalytical services and pharmacokinetic (PK) studies for the pharmaceutical and biotech industries. Based in Frankfurt, the company provides GLP and GCP-compliant bioanalysis for both small molecules and large molecules, including proteins and monoclonal antibodies. Prolytic supports drug development from preclinical stages through clinical trials, offering expertise in method development, validation, and high-throughput sample analysis. In 2020, the company was acquired by Kymos, a Spanish CRO, which integrated Prolytic into its group to expand its European footprint and bioanalytical capabilities. The company is recognized for its technical proficiency in LC-MS/MS and ligand binding assays.